Ongoing trials involving angiotensin-converting enzyme inhibitors

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.11, Iss.11, 2002-11, pp. : 1633-1643

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical trials evaluating angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the setting of acute myocardial infarction

By Salam Amar M

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. : 501-507

Informa Healthcare

Access to resources Recommend Favorite

Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors

Current Pharmaceutical Design, Vol. 21, Iss. 13, 2015-04 ,pp. : 1764-1775

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of angiotensin II and angiotensin-converting enzyme inhibitors on human myocardium

By Lenz O. Schmid B. Kilter H. La Rosee K. Flesch M. Kuhn-Regnier F. Sudkamp M. Bohm M.

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 17-27

Elsevier

Access to resources Recommend Favorite

Safety issues associated with the use of angiotensin-converting enzyme inhibitors

By Ehlers Mario R

Expert Opinion on Drug Safety, Vol. 5, Iss. 6, 2006-11 ,pp. : 739-740

Informa Healthcare

Access to resources Recommend Favorite

Angiotensin-converting enzyme inhibitors can potentiate ozone-induced airway hyperresponsiveness

By Matsubara S. Kikkawa H. Kaminuma O. Ikezawa K.

European Journal of Pharmacology, Vol. 337, Iss. 2, 1997-10 ,pp. : 259-265

Elsevier

Access to resources Recommend Favorite